Blog - Page 2163 of 5730

FridayNov 30, 2018 9:21 am

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Building New Capacity upon First Commercial Cannabis Crop

Full-scale cannabis legalization in Canada in October led to a rush of consumer interest and a resultant shortage of supply as the new industry adapts The Green Organic Dutchman is improving on its initial commercial crop by building facilities with 195,000 kilograms of annual production capacity The company’s reach includes cultivation facilities in Canada and Jamaica, with additional hemp production in Poland Vast distribution capabilities spread wide across Canada, Jamaica, Mexico and Europe Soaring demand for legal cannabis products has strengthened the long-term outlook for cannabis cultivator The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), which is expanding…

ThursdayNov 29, 2018 12:05 pm

QualityStocksNewsBreaks – Medical Cannabis Payment Solutions’ (REFG) Proprietary Payment System Promotes Security

Medical Cannabis Payment Solutions (OTC: REFG) is serving the legal cannabis industry with its proprietary, FinCEN (Financial Crimes Enforcement Network) compliant, end-to-end payment processing solution. By providing an alternative to operating strictly in cash, the system encourages security by enabling business to go cashless. A recent article discussing the company reads, “The company provides payment and management solutions that are integrable for medical and recreational dispensaries and businesses (http://ibn.fm/Wd6rI). Essentially, as a first-tier merchant processing cannabis industry pioneer, Medical Cannabis Payment Solutions offers one of the first and only wide-ranging card processing operations of its type. This is primarily to…

ThursdayNov 29, 2018 11:59 am

Sugarmade, Inc.’s (SGMD) Hydroponic Solutions Could Fast Track Growth of US Hemp Industry

U.S. hemp industry set for CAGR of 14 percent through 2022 Interest in 23,000-acre ultra-high cannabidiol (CBD) hemp project in Kentucky Raises revenue guidance for 2019 to $70 million after announcing acquisition of hydroponics retailer Despite the abstrusity that still surrounds the legal status of hemp, cultivation of the plant in the U.S. is undergoing a renaissance. During the Republic’s early years, citizens were legally obliged to grow the crop, and both Presidents Washington and Jefferson are reported to have done so. But legislative changes turned the thing on its head. Since hemp was a strain of cannabis sativa, as was…

ThursdayNov 29, 2018 11:39 am

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) to Present Key Updates of Immuno-Oncology Tech at 2018 San Antonio Breast Cancer Symposium

BriaCell Therapeutics Corp. is working to develop the first off-the-shelf personalized immunotherapy for advanced breast cancer Clinical data reveals an excellent safety profile and potent anti-tumor activity for Bria-IMT in advanced breast cancer patients Combination study using Bria-IMT with Merck & Co., Inc.’s KEYTRUDA (pembrolizumab) in advanced breast cancer patients is ongoing Symposium covers the latest research on experimental biology, etiology, prevention, diagnosis and treatment of breast cancer and premalignant breast disease International audience from over 90 countries includes researchers, health professionals, physicians, oncologists and those with a special interest in breast cancer An immuno-oncology focused biotechnology company, BriaCell Therapeutics…

ThursdayNov 29, 2018 11:18 am

SinglePoint, Inc. (SING) Riding High as New CBD Products Enter Fast Growing Legal Marketplace

SinglePoint’s cannabis market subsidiaries building direct-to-consumer supply chain for CBD products SingleSeed subsidiary introduced infused water and muscle salve products in October, with new sleep aid and a hair and beard oil expected promptly CBD is gaining traction as a medicinal product and wellness industry ingredient after Canada’s legalization drive and growing lawfulness in the United States Technology innovator SinglePoint, Inc. (OTCQB: SING) is celebrating the rollout of new products to the cannabis-infused wellness market by subsidiary SingleSeed at the same time that its already-launched Lalpina CBD Water is reporting a successful first week of sales. SingleSeed distributes hemp-based CBD…

ThursdayNov 29, 2018 11:10 am

QualityStocksNewsBreaks – Why Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) is “One to Watch”

Sproutly Canada (OTC: SRUTF) (CSE: SPR) (FRA: 38G) is engaged in developing and bringing to market cannabis consumer products with a focus on beverages. A recent article discussing the company reads, “Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined…

ThursdayNov 29, 2018 10:55 am

QualityStocksNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Releases Results for the Third Quarter and Nine Months Ended September 30, 2018

Canadian Licensed Producer of premium cannabis products The Flowr Corporation (TSX.V: FLWR) has announced its results for the third quarter and nine months ended September 30, 2018. The update provided business highlights, with financials reported in Canadian dollars, including: Completion of almost $65 million in fundraising throughout 2017 and 2018; culminating in a nearly $36 million raise as part of the reverse takeover transaction leading to FLWR’s listing on the TSX Venture Exchange; Kelowna, BC facility cultivation and harvesting a total of 358,768 grams; Health Canada sales license and entry into supply agreements with provincial authorities from British Columbia, Nova…

ThursdayNov 29, 2018 10:52 am

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is “One to Watch”

Delivers effective, non-invasive, pain free skin care through its proprietary thermal therapy device technology Products approved by FDA and Health Canada as Class II medical devices Current product InterceptCS™ treats cold sores by application of controlled topical heat with no risk of burning the skin Current product TherOZap™ relieves pain, itch and inflammation of more than 20,000 types of insect and marine life bites and stings Future product now in R&D will incorporate thermal therapy device with medical cannabis or CBD gel, cream or salve Completed full IP review of patents, trademarks, and regulatory approvals for thermal therapy technology Global…

ThursdayNov 29, 2018 10:40 am

QualityStocksNewsBreaks – CytoDyn Inc.’s (CYDY) PCaTest Clinical Study Results Demonstrate Added Value to Gleason Score, Further Support FDA filing

Biotechnology company CytoDyn (OTCQB: CYDY) today announced recent clinical study results showing that its PCaTest provides substantial additive value for predicting outcomes for prostate cancer patients compared to the Gleason score, the current standard for prostate cancer diagnosis. The new findings support CYDY’s strategy for seeking FDA approval for the PCaTest. “Unfortunately, current tests not able to precisely determine whether an individual’s cancer will result in death if not treated aggressively,” CytoDyn Chief Medical Officer and developer of the PCaTest Richard Pestell , M.D., Ph.D., F.A.C.P., M.B.A., stated in the news release. “On the other hand, aggressive treatment for prostate…

Site Search

Company Search